SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates 
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing 
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning 
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links 
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised 
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings 
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge 
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million 
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine 
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns 
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off 
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil 
Ford and Geely Explore Strategic Manufacturing Partnership in Europe 
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO 
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit 
Instagram Outage Disrupts Thousands of U.S. Users 
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains 
 Shares Announced by Shareholders Foundation - EconoTimes)
SAN DIEGO, Jan. 27, 2016 -- The Shareholders Foundation, Inc. announces that a lawsuit was filed in New York on behalf of certain investors who purchased of shares of Anavex Life Sciences Corp. (NASDAQ:AVXL) over alleged Securities Laws Violations by Anavex Life Sciences.
Investors who purchased shares of Anavex Life Sciences Corp. (NASDAQ:AVXL) have certain options and for certain investors are short and strict deadlines running. Deadline: February 29, 2016. (NASDAQ:AVXL) investors should contact the Shareholders Foundation at [email protected] or call +1(858) 779 - 1554.
The plaintiff claims that the defendants made certain allegedly false and/or misleading statements and/or allegedly failed to disclose that Anavex had used a paid stock promoter to artificially inflate the Company’s share price and that as a result of the foregoing, Anavex’s public statements were materially false and misleading at all relevant times.
On December 29, 2015, Anavex Life Sciences Corp. disclosed that it had received a subpoena from the U.S. Securities and Exchange Commission (“SEC”) on December 22, 2015. Anavex Life Sciences Corp. stated, in part, that "[t]he Company believes the subpoena and investigation relate to the recent unusual activity in the market for the Company's shares."
On December 30, 2015, a report was published entitled “Anavex: A Regulatory Target Damaged By Incriminating Evidence.”
Those who purchased (NASDAQ:AVXL) shares have certain options and should contact the Shareholders Foundation, Inc. by e-mail at [email protected] or call +1 (858) 779-1554.
The Shareholders Foundation, Inc. is a professional portfolio legal monitoring and a settlement claim filing service, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. The Shareholders Foundation, Inc. is not a law firm. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
CONTACT: Shareholders Foundation, Inc.
Michael Daniels
+1 (858) 779-1554
[email protected]
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
